Results 301 to 303 of about 9,793 (303)

Human medicines European public assessment report (EPAR): Takhzyro, lanadelumab, Angioedemas, Hereditary, Date of authorisation: 22/11/2018, Status: Authorised

Case Medical Research
exaly  

Human medicines European public assessment report (EPAR): Firazyr, icatibant, Angioedemas, Hereditary, Date of authorisation: 11/07/2008, Revision: 16, Status: Authorised

Case Medical Research
exaly  

[Angioedema].

Nihon rinsho. Japanese journal of clinical medicine, 2013
openaire   +1 more source